Development of a Real-Time Loop-Mediated Isothermal Amplification Method for the Detection of West Nile Virus

AUTHORS

Jae Woong Lee 1 , Yu-Jung Won 1 , Sung-Geun Lee 2 , Soon-Young Paik ORCID 1 , *

1 Department of Microbiology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea

2 Korea Zoonosis Research Institute, Jeonbuk National University, Iksan, Republic of Korea

How to Cite: Lee J W, Won Y, Lee S, Paik S. Development of a Real-Time Loop-Mediated Isothermal Amplification Method for the Detection of West Nile Virus. Jundishapur J Microbiol. 2020;13(10):e105443. doi: 10.5812/jjm.105443.

ARTICLE INFORMATION

Jundishapur Journal of Microbiology: 13 (10); e105443
Published Online: December 8, 2020
Article Type: Research Article
Received: September 5, 2020
Revised: November 15, 2020
Accepted: November 19, 2020
Crossmark
Crossmark
CHECKING
READ FULL TEXT

Abstract

Background: The West Nile Virus (WNV), discovered in New York, USA in 1999 after it was first isolated in Uganda in 1937, has since spread not only in the United States but also around the world. Africa, Eurasia, Australia, and the Middle East have sporadic cases of the disease.

Objectives: We aimed to find real-time reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay to be more sensitive than conventional RT-PCR, and more rapid and efficient than conventional RT-PCR and real-time RT-PCR for WNV detection.

Methods: A total of 32 genomic sequences from different strains of WNV were analyzed to identify conserved nucleotide sequence regions. Six WNV specific RT-LAMP primers targeting the E gene were designed.

Results: The novel primer for the real-time RT-LAMP assay can detect WNV with high specificity. The efficiency of the real-time RT-LAMP assay is higher than the conventional RT-PCR and real-time RT-PCR. Real-time RT-PCR and conventional PCR require at least 30 – 40 min and 2 h, respectively, to yield results, whereas real-time RT-LAMP provides positive results in only 10 – 20 min.

Conclusions: The novel primers were developed by analyzing of 32 genomic sequences of WNV strains. The primers were designed from the most conserved region of the E gene for real-time RT-LAMP. The LAMP assay is a rapid, efficient, highly sensitive, and specific tool for the identification of WNV.

1. Background

The West Nile Virus (WNV) belongs to genus Flavivirus of the family Flaviviridae (1). Lineage 1 and 2 of WNV are associated with significant human outbreaks and are designated into at least 5 phylogenetic lineages (2). The genome of WNV is about 11 kb in length with a single-stranded positive-sense RNA, which encodes seven non-structural (NS) proteins and three structural proteins (C, capsid; M, membrane; and E, envelope) (3). The structural proteins constitute the virus particle while the NS proteins are essential for viral replication (4). The WNV is widespread all over the world and is transmitted by birds and mosquitoes (5). More than 34,000 cases have been reported in United States, with an estimated 7 million cases between 1999 and 2016 (6). WNV infection is defined as cases confirmed by laboratories.

On the basis of laboratory diagnosis involving virus identification by reverse transcription PCR (RT-PCR) or specific antibody detection techniques such as enzyme-linked immunosorbent assay (ELISA) or virus-neutralization (7). However, these methods are time consuming and require technical expertise. Hence, a rapid, simple, sensitive, and efficient method is required to reduce the incidence of WNV cases and infection. Loop-mediated isothermal amplification (LAMP) is simple and the most popular isothermal technology for in vitro nucleic acid amplification (8). The LAMP assay is highly sensitive and able to detect low copy numbers of DNA and is also applicable to RNA using reverse transcriptase. Only primers, polymerase, and a heat block are required to perform the LAMP. Advantages of the LAMP method include the ability to amplify nucleic acid with high specificity, efficiency, and rapidity under isothermal conditions (9). In this study, a newly designed primer was used to efficiently diagnose WNV using the real-time reverse transcription loop-mediated isothermal amplification (RT-LAMP) method.

2. Objectives

This study, we found real-time reverse transcription LAMP (RT-LAMP) assay to be more sensitive than conventional RT-PCR, and more rapid and efficient than conventional RT-PCR and real-time RT-PCR. It will be useful for quick detection of WNV infection and will contribute to the epidemiology study.

3. Methods

3.1. Virus Sample and Ethics Statement

The West Nile Virus serum and plasma sample was obtained from Boca Biolistics (Pompano Beach, Florida, USA; https://www.bocabio.com/). Since this study does not involve patients, the use of these samples was reviewed and approved by the Institutional Review Board for the purpose of research. The Catholic Medical Center Office of the Human Research Protection Program (CMC OHRP) of South Korea (approval number MC19SESI0015) supervised all experimental work and sample collection.

3.2. Viral RNA Extraction

A Bio Safety Level 3 (BSL-3) facility was used for in vitro experiments at the Korea Zoonosis Research Institute, Jeonbuk National University. The control RNA viruses were Zika virus, chikungunya virus, influenza virus (H5N1), severe fever with thrombocytopenia syndrome virus (SFTSV), Japanese encephalitis virus (JEV), and dengue viruses 2 and 3 (DENV-2, DENV-3). Viral RNAs were extracted from the viral stocks using QIAamp Viral RNA Mini Kits (#52906; Qiagen, Hilden, Germany) according to the manufacturer’s instructions.

3.3. Design of Primers

A total of 32 genomic sequences of WNV were obtained from GenBank (https://www.ncbi.nlm.nih.gov/genbank/), and conserved nucleotide sequence regions were identified using CLC Main Workbench 7 (version 7.6.4.). Six WNV-specific RT-LAMP primers targeting the E gene were designed. These primers consist of two external primers (F3 and B3), two internal primers (FIP and BIP), and two loop primers (LoopF and LoopB) (Table 1). The Korea National Institute of Health (KNIH) standard protocol was used for conventional RT-PCR using the primers WN-21F (5′-TGACAACTTAGTAGGTTTG-3′) and WN-550R (5′-CAGCTGTTGTAATCGTGATG-3′). The real-time RT-PCR primers were as described in previous research (10). The primers NS1-F (5′-GCCATATGGTACATGTGGCTGGGAGC-3′) and NS1-R (5′-GTKATTCTTGTGTCCCAWCCGGCTGTGTCATC-3′) were designed to bind to the conserved region of the NS5 segment of WNV.

Table 1. Real-Time LAMP Assay Primer
Primers′ NameSequence (5′- 3′)Location in Genome a
WNV-F3AGAATATGGAGAGGTGACAGT1500 - 1520
WNV-B3AATTCCACAGGAATGGCTC1760 - 1778
WNV-FIPGGAGGTTGAGGTCCATGAACCTGCATACTACGTGATGACTG1607 - 1627, 1555 - 1574
WNV-BIPTGCTGGAAGTACTGTATGGAGGACAATGCTATCACAGACTGCT1703 - 1722, 1638 - 1660
WNV_LoopFACTCACGATGGACCAAGAAC1587 - 1606
WNV_LoopBGAACCACACGCCACGA1687 - 1702

aGenome position according to WNV complete sequence (GenBank accession number KY229069).

3.4. PCR and Amplification

Conventional RT-PCR followed the KNIH standard protocol. The reverse transcription was performed at 50°C for 30 min, then 95°C for 15 min. Amplification occurred under 35 cycles of 94°C for 30 s, 52°C for 30 s, and 72°C for 1 min, followed by a final extension at 72°C for 10 min. For the real-time RT-PCR, the iTaqTM Universal SYBR Green One-Step Kit (#172-5150; BIO-RAD, Hercules, CA, USA,) and a Bio-Rad CFX96TM system were used. The reverse transcription was performed for 10 min at 50°C, and polymerase activation and DNA denaturation for 1 min at 95°C. The amplification followed with 10 s at 95°C for denaturation, and 30 s at 60°C for annealing/extension under 40 cycles. Real-time RT-LAMP was performed for 50 min at 65°C using a WarmStart LAMP Kit (#E1700; New England Biolabs, Ipswich, MA, USA).

3.5. Synthesis of RNA Transcripts

Calculation of copy numbers and synthesis of RNA transcripts were performed as described in previous studies (11, 12). Three types of RNA transcripts were prepared for assays: real-time RT-LAMP, conventional RT-PCR, and real-time RT-PCR; each transcript contained the primer sequence regions. RNA transcripts were used as templates after 10-fold serial dilutions from 5 × 106 down to 5 × 101 copies. The efficiency and sensitivity of the three assays were evaluated.

4. Results

4.1. Specificity of The Real-Time RT-LAMP Assay

For the specificity test, extracted viral RNA was used as template for the real-time RT-LAMP assay. Novel primers were used for detection (Table 1). The results were positive for WNV, while SFTSV, JEV, DENV-2, DENV-3, Zika virus, chikungunya virus, and H5N1 were not amplified (Figure 1). These results indicate that the novel primer for the real-time RT-LAMP assay can detect WNV with high specificity.

Figure 1. RNA extracted from West Nile Virus (WNV) was amplified by the real-time RT-LAMP assay, however no products were amplified from the control viral RNA. Control viruses: Zika virus, chikungunya virus, influenza virus (H5N1), severe fever with thrombocytopenia syndrome virus (SFTSV), Japanese encephalitis virus (JEV), and dengue viruses 2 and 3 (DENV-2, DENV-3).

4.2. Sensitivity and Efficiency Test for WNV Detection

We compared the efficiency and sensitivity of WNV detection in conventional RT-PCR, real-time RT-PCR, and real-time LAMP assay. Known concentrations of diluted WNV RNA transcripts (5 × 101 – 5 × 106 copies) were used as templates. Real-time RT-PCR and real-time LAMP assays were used to amplify the targeted RNA with a detection limit of 5 × 101 copies (Table 2). The detection limit of conventional RT-PCR was 5 × 102 copies (Figure 2). These results show that real-time RT-LAMP is more sensitive than conventional RT-PCR. Real-time RT-LAMP assay is more efficient than conventional RT-PCR and real-time RT-PCR, and provided results within 9 to 18 min. In contrast, real-time RT-PCR provided results after 35 min (21 to 35 cycles) at the same WNV RNA copy number (Table 2). Moreover, conventional RT-PCR required an additional 6 h to yield results after performing a second PCR using agarose gel.

Figure 2. Diluted West Nile Virus (WNV) RNA was used for detection sensitivity and efficiency tests. Serial dilution of WNV RNA, ranging between 5 × 106 and 5 × 101 were evaluated by (A) conventional RT-PCR, (B) real-time RT-PCR, and (C) real-time RT-LAMP assay, and detections limit was 5 × 102, 5 × 101, and 5 × 101 copies respectively. The real-time LAMP assay showed results in 9 – 18 min; however, the other two methods took at least 35 min to over 6 h.
Table 2. Time Values for Real-Time RT-PCR and Real-Time LAMP Assay
Template ConcentrationReal-Time RT-PCR, Time a(Cycle)Real-Time LAMP Assay, Time
10525:28/26:00/26:14, 21.69/22.51/22.869:54/9:54/10:05
10428:20/28:41/28:49, 26.01/26.53/26.7311:16/11:35/11:58
10330:32/31:33/32:02, 29.31/30.83/31.5513:05/13:29/13:42
10231:39/32:32/33:18, 30.97/32.31/33.4417:31/17:58/18:36
10134:19/N. D/N. D, 34.98/N. D/N. D17:42/N. D/N. D

Abbreviation: N.D, no data.

a Time (mm:ss).

5. Discussion

Since its emergence in New York City in 1999, WNV has become endemic in the United States (6, 13). WNV has annual seasonal outbreaks. Most commonly, patients are asymptomatic but fever symptoms occurs in 20% of the population, and < 1% progress to WNND, which might include acute flaccid paralysis, meningitis, and encephalitis (6). The research group estimates average costs for treating hospitalized WNV patients to be US $56 million annually and US $700,000 per patient for initial and long-term cases (14, 15). WNV burdens many countries, not only the United States (2, 16-18). To reduce the WNV burden and outbreaks, a quick and accurate diagnostic method is required. The conventional diagnosis methods used ELISA and quantitative real-time RT-PCR (19-24). These methods target the E gene or a neutralizing epitope within the envelope such as E glycoprotein. In this study, we designed a primer targeting the most conserved region of the E gene. ELISA, conventional RT-PCR, and real-time RT-PCR have limitations such as being time-consuming, low sensitivity, and being highly technical. LAMP assay is a simple, rapid, and accurate method that can be used for the detection of several RNA viruses including WNV (25-29). Our results show that the LAMP assay is about 10-fold more sensitive than conventional RT-PCR.

The results also show that it is much more efficient and rapid than conventional RT-PCR and real-time RT-PCR, which take at least 35 min to 6 h and require an additional step for confirmation. However, by using the novel designed primers for LAMP assay we were able to confirm the presence of WNV in 18 min. We interpret the detection of Real-time RT-LAMP and real-time RT-PCR as 5 × 101 copies, because the limit reaction is the minimum detection limit. WNV poses a threat to public health in many countries around the world and is also an economic burden. This virus has undergone a rapid geographical spread over the past few decades (14, 30). To reduce this, rapid and efficient diagnostic methods must be developed. This study found the LAMP assay to be the best diagnostic method for WNV detection. We expect our methods to be helpful to researchers and clinicians.

5.1. Conclusions

In conclusion, novel primers were developed by analyzing of 32 genomic sequences of WNV strains. The primers were designed from the most conserved region of the E gene for real-time RT-LAMP. The LAMP assay is a rapid, efficient, highly sensitive, and specific tool for the identification of WNV. It will be useful for quick detection of WNV infection and will contribute to the epidemiology study.

Footnotes

References

  • 1.

    Kuno G, Chang GJ, Tsuchiya KR, Karabatsos N, Cropp CB. Phylogeny of the genus Flavivirus. J Virol. 1998;72(1):73-83. doi: 10.1128/JVI.72.1.73-83.1998. [PubMed: 9420202]. [PubMed Central: PMC109351].

  • 2.

    May FJ, Davis CT, Tesh RB, Barrett AD. Phylogeography of West Nile virus: from the cradle of evolution in Africa to Eurasia, Australia, and the Americas. J Virol. 2011;85(6):2964-74. doi: 10.1128/JVI.01963-10. [PubMed: 21159871]. [PubMed Central: PMC3067944].

  • 3.

    Martin-Acebes MA, Saiz JC. West Nile virus: A re-emerging pathogen revisited. World J Virol. 2012;1(2):51-70. doi: 10.5501/wjv.v1.i2.51. [PubMed: 24175211]. [PubMed Central: PMC3782267].

  • 4.

    Mukhopadhyay S, Kuhn RJ, Rossmann MG. A structural perspective of the flavivirus life cycle. Nat Rev Microbiol. 2005;3(1):13-22. doi: 10.1038/nrmicro1067. [PubMed: 15608696].

  • 5.

    Kramer LD, Styer LM, Ebel GD. A global perspective on the epidemiology of West Nile virus. Annu Rev Entomol. 2008;53:61-81. doi: 10.1146/annurev.ento.53.103106.093258. [PubMed: 17645411].

  • 6.

    Ronca SE, Murray KO, Nolan MS. Cumulative incidence of West Nile Virus infection, continental United States, 1999-2016. Emerg Infect Dis. 2019;25(2):325-7. doi: 10.3201/eid2502.180765. [PubMed: 30666940]. [PubMed Central: PMC6346444].

  • 7.

    Rebollo B, Sarraseca J, Rodriguez MJ, Sanz A, Jimenez-Clavero MA, Venteo A. Diagnostic aptitude of West Nile virus-like particles expressed in insect cells. Diagn Microbiol Infect Dis. 2018;91(3):233-8. doi: 10.1016/j.diagmicrobio.2018.02.003. [PubMed: 29530349].

  • 8.

    Mori Y, Notomi T. Loop-mediated isothermal amplification (LAMP): Expansion of its practical application as a tool to achieve universal health coverage. J Infect Chemother. 2020;26(1):13-7. doi: 10.1016/j.jiac.2019.07.020. [PubMed: 31519395].

  • 9.

    Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 2000;28(12). E63. doi: 10.1093/nar/28.12.e63. [PubMed: 10871386]. [PubMed Central: PMC102748].

  • 10.

    Yang CF, Chen CF, Su CL, Teng HJ, Lu LC, Lin C, et al. Screening of mosquitoes using SYBR Green I-based real-time RT-PCR with group-specific primers for detection of Flaviviruses and Alphaviruses in Taiwan. J Virol Methods. 2010;168(1-2):147-51. doi: 10.1016/j.jviromet.2010.05.006. [PubMed: 20471427].

  • 11.

    Devonshire AS, Elaswarapu R, Foy CA. Applicability of RNA standards for evaluating RT-qPCR assays and platforms. BMC Genomics. 2011;12:118. doi: 10.1186/1471-2164-12-118. [PubMed: 21332979]. [PubMed Central: PMC3052187].

  • 12.

    Lee SG, Lee SH, Park SW, Suh CI, Jheong WH, Oh S, et al. Standardized positive controls for detection of norovirus by reverse transcription PCR. Virol J. 2011;8:260. doi: 10.1186/1743-422X-8-260. [PubMed: 21612660]. [PubMed Central: PMC3127839].

  • 13.

    Nash D, Mostashari F, Fine A, Miller J, O'Leary D, Murray K, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med. 2001;344(24):1807-14. doi: 10.1056/NEJM200106143442401. [PubMed: 11407341].

  • 14.

    Barrett ADT. Economic burden of West Nile virus in the United States. Am J Trop Med Hyg. 2014;90(3):389-90. doi: 10.4269/ajtmh.14-0009. [PubMed: 24515938]. [PubMed Central: PMC3945680].

  • 15.

    Staples JE, Shankar MB, Sejvar JJ, Meltzer MI, Fischer M. Initial and long-term costs of patients hospitalized with West Nile virus disease. Am J Trop Med Hyg. 2014;90(3):402-9. doi: 10.4269/ajtmh.13-0206. [PubMed: 24515937]. [PubMed Central: PMC3945683].

  • 16.

    Mbanzulu KM, Mboera LEG, Luzolo FK, Wumba R, Misinzo G, Kimera SI. Mosquito-borne viral diseases in the Democratic Republic of the Congo: a review. Parasit Vectors. 2020;13(1):103. doi: 10.1186/s13071-020-3985-7. [PubMed: 32103776]. [PubMed Central: PMC7045448].

  • 17.

    Simulundu E, Ndashe K, Chambaro HM, Squarre D, Reilly PM, Chitanga S, et al. West Nile Virus in farmed crocodiles, Zambia, 2019. Emerg Infect Dis. 2020;26(4):811-4. doi: 10.3201/eid2604.190954. [PubMed: 32187004]. [PubMed Central: PMC7101096].

  • 18.

    Holt E. West Nile virus spreads in Europe. Lancet Infect Dis. 2018;18(11):1184. doi: 10.1016/S1473-3099(18)30616-9. [PubMed: 30507404].

  • 19.

    Sotelo E, Llorente F, Rebollo B, Camunas A, Venteo A, Gallardo C, et al. Development and evaluation of a new epitope-blocking ELISA for universal detection of antibodies to West Nile virus. J Virol Methods. 2011;174(1-2):35-41. doi: 10.1016/j.jviromet.2011.03.015. [PubMed: 21419800].

  • 20.

    Lorono-Pino MA, Farfan-Ale JA, Blitvich BJ, Beebe JL, Jarman RG, Beaty BJ. Evaluation of an epitope-blocking enzyme-linked immunosorbent assay for the diagnosis of West Nile virus infections in humans. Clin Vaccine Immunol. 2009;16(5):749-55. doi: 10.1128/CVI.00393-08. [PubMed: 19321694]. [PubMed Central: PMC2681594].

  • 21.

    Fall G, Faye M, Weidmann M, Kaiser M, Dupressoir A, Ndiaye EH, et al. Real-Time RT-PCR assays for detection and genotyping of West Nile Virus Lineages Circulating in Africa. Vector Borne Zoonotic Dis. 2016;16(12):781-9. doi: 10.1089/vbz.2016.1967. [PubMed: 27710313].

  • 22.

    Kumar JS, Saxena D, Parida M. Development and comparative evaluation of SYBR Green I-based one-step real-time RT-PCR assay for detection and quantification of West Nile virus in human patients. Mol Cell Probes. 2014;28(5-6):221-7. doi: 10.1016/j.mcp.2014.03.005. [PubMed: 24732288].

  • 23.

    Barros SC, Ramos F, Ze-Ze L, Alves MJ, Fagulha T, Duarte M, et al. Simultaneous detection of West Nile and Japanese encephalitis virus RNA by duplex TaqMan RT-PCR. J Virol Methods. 2013;193(2):554-7. doi: 10.1016/j.jviromet.2013.07.025. [PubMed: 23892127].

  • 24.

    Kleiboeker SB, Loiacono CM, Rottinghaus A, Pue HL, Johnson GC. Diagnosis of West Nile virus infection in horses. J Vet Diagn Invest. 2004;16(1):2-10. doi: 10.1177/104063870401600102. [PubMed: 14974840].

  • 25.

    Fukuta S, Iida T, Mizukami Y, Ishida A, Ueda J, Kanbe M, et al. Detection of Japanese yam mosaic virus by RT-LAMP. Arch Virol. 2003;148(9):1713-20. doi: 10.1007/s00705-003-0134-5. [PubMed: 14505084].

  • 26.

    Wang H, Cong F, Zeng F, Lian Y, Liu X, Luo M, et al. Development of a real time reverse transcription loop-mediated isothermal amplification method (RT-LAMP) for detection of a novel swine acute diarrhea syndrome coronavirus (SADS-CoV). J Virol Methods. 2018;260:45-8. doi: 10.1016/j.jviromet.2018.06.010. [PubMed: 29936095]. [PubMed Central: PMC7113678].

  • 27.

    Baek YH, Cheon HS, Park SJ, Lloren KKS, Ahn SJ, Jeong JH, et al. Simple, rapid and sensitive portable molecular diagnosis of SFTS virus using reverse transcriptional loop-mediated isothermal amplification (RT-LAMP). J Microbiol Biotechnol. 2018;28(11):1928-36. doi: 10.4014/jmb.1806.06016. [PubMed: 30270605].

  • 28.

    Parida M, Shukla J, Sharma S, Ranghia Santhosh S, Ravi V, Mani R, et al. Development and evaluation of reverse transcription loop-mediated isothermal amplification assay for rapid and real-time detection of the swine-origin influenza A H1N1 virus. J Mol Diagn. 2011;13(1):100-7. doi: 10.1016/j.jmoldx.2010.11.003. [PubMed: 21227400]. [PubMed Central: PMC3069812].

  • 29.

    Jiang T, Liu J, Deng YQ, Xu LJ, Li XF, Han JF, et al. Development and evaluation of a reverse transcription-loop-mediated isothermal amplification assay for rapid detection of enterovirus 71. J Clin Microbiol. 2011;49(3):870-4. doi: 10.1128/JCM.02045-10. [PubMed: 21177907]. [PubMed Central: PMC3067723].

  • 30.

    Gray TJ, Webb CE. A review of the epidemiological and clinical aspects of West Nile virus. Int J Gen Med. 2014;7:193-203. doi: 10.2147/IJGM.S59902. [PubMed: 24748813]. [PubMed Central: PMC3990373].

  • Copyright © 2020, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
    COMMENTS

    LEAVE A COMMENT HERE: